Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ludmila Krymskaya"'
Autor:
Laura Amo, Hemanta K. Kole, Bethany Scott, Chen-Feng Qi, Ludmila Krymskaya, Hongsheng Wang, Louis H. Miller, Chris J. Janse, Silvia Bolland
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The host response against infection with Plasmodium commonly raises self-reactivity as a side effect, and antibody deposition in kidney has been cited as a possible cause of kidney injury during severe malaria. In contrast, animal models show that in
Externí odkaz:
https://doaj.org/article/0f869c92b43f4e68b3ed692d7e949c53
Autor:
Sean V. Connelly, Javier Manzella-Lapeira, Zoë C. Levine, Joseph Brzostowski, Ludmila Krymskaya, Rifat S. Rahman, Angela C. Ellis, Shuchi N. Amin, Juliana M. Sá, Thomas E. Wellems
Publikováno v:
mBio, Vol 12, Iss 3 (2021)
The major first-line treatment for malaria, especially the deadliest form caused by Plasmodium falciparum
Externí odkaz:
https://doaj.org/article/31fdd0b4cec14451bead7dd21644d70a
Autor:
Richard Jove, Stephen Forman, Hua Yu, David DiGiusto, Lawrence M. Weiss, Lin Wang, Ludmila Krymskaya, Claudia Kowolik, Maciej Kujawski, Anna Scuto
Supplementary Figure Legends 1-3 from STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9001e599d15867ba5f7f09e19191c76c
https://doi.org/10.1158/0008-5472.22390913.v1
https://doi.org/10.1158/0008-5472.22390913.v1
Autor:
Richard Jove, Stephen Forman, Hua Yu, David DiGiusto, Lawrence M. Weiss, Lin Wang, Ludmila Krymskaya, Claudia Kowolik, Maciej Kujawski, Anna Scuto
Supplementary Figure 3 from STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77532fa657a2ff4367fd28546fbcfbb6
https://doi.org/10.1158/0008-5472.22390919.v1
https://doi.org/10.1158/0008-5472.22390919.v1
Autor:
Richard Jove, Stephen Forman, Hua Yu, David DiGiusto, Lawrence M. Weiss, Lin Wang, Ludmila Krymskaya, Claudia Kowolik, Maciej Kujawski, Anna Scuto
Supplementary Figure 1 from STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79df60880ffd58af9850cb3a2eff26c1
https://doi.org/10.1158/0008-5472.22390925
https://doi.org/10.1158/0008-5472.22390925
Autor:
Javier Manzella-Lapeira, Thomas E. Wellems, Joseph Brzostowski, Shuchi N Amin, Angela C. Ellis, Ludmila Krymskaya, Sean V. Connelly, Juliana M. Sá, Zoë C Levine, Rifat S. Rahman
Publikováno v:
mBio, Vol 12, Iss 3 (2021)
mBio
mBio
Artemisinin and its semi-synthetic derivatives (ART) are fast acting, potent antimalarials; however, their use in malaria treatment is frequently confounded by recrudescences from bloodstream Plasmodium parasites that enter into and later reactivate
Autor:
Tong Li, Ping Chen, Steven Godin, Jie Cheng, Jing Qin, Ludmila Krymskaya, Marta Catalfamo, Maha Moussa, Michael C. Sneller, Jeffrey D. Lifson, H. Clifford Lane, Hui Chen
Publikováno v:
J Infect Dis
Background The PD1/PD-L1 pathway contributes to the pathogenesis of human immunodeficiency virus (HIV)/simian immunodeficiency virus (SIV) infection, and blockade of this pathway may have potential to restore immune function and promote viral control
Autor:
Francesca Mascia, Christophe Cataisson, Ludmila Krymskaya, Stuart H. Yuspa, Karen M. Wolcott, Katherine M. McKinnon, Derek T. Schloemann
Publikováno v:
International Journal of Cancer. 139:2593-2597
Targeting mutations and amplifications in the EGFR has been successful precision therapy for cancers of the lung, oral cavity and gastrointestinal track. However, a systemic immune reaction manifested by dose-limiting inflammation in the skin and gut
Autor:
Maha MOUSSA, Jie Cheng, Ping Chen, Hui Chen, Tong Li, Jing Qin, Jeffrey D. Lifson, Michael C. Sneller, Ludmila Krymskaya, Steven Godin, Clifford Lane, Marta Catalfamo
Publikováno v:
The Journal of Immunology. 202:72.13-72.13
The PD1/PD-L1 pathway contributes to the pathogenesis of HIV/SIV infection. Expression of PD1 by HIV/SIV-specific CD8 T cells can limit antiviral responses and expression of checkpoint receptors including PD1 by HIV infected cells can contribute to m
Autor:
David DiGiusto, Evan Lopez, Jianbin Wang, Pei-Qi Liu, Agnes M. Gardner, Jill Henley, Nancy Gonzalez, Michael C. Holmes, Ludmila Krymskaya, Paula M. Cannon, Qing Liu, Anitha Rao, John A. Zaia, Lijing Li, Chy-Anh Tran, Ursula Hofer, Lan-Feng Cao, Kenneth Kim, Monica Torres-Coronado, Philip D. Gregory
Publikováno v:
Molecular Therapy
The HIV-1 coreceptor CCR5 is a validated target for HIV/AIDS therapy. The apparent elimination of HIV-1 in a patient treated with an allogeneic stem cell transplant homozygous for a naturally occurring CCR5 deletion mutation (CCR5(Δ32/Δ32)) support